For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
|Articles|August 31, 2015
Anjee Davis on the Future of Research and Advocacy in Colorectal Cancer
Author(s)Anjee Davis
Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates.
Advertisement
Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates. We spoke with Davis at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago in May and June.
Advertisement
Related to this article
Patients with colorectal cancer who walked more had less fatigue and better quality of life, regardless of how active they were at diagnosis.
In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatment.
Advertisement
Advertisement
Trending on CURE
1
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
2
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
3
I’m Jealous of the World — and Grateful I Got to Be Part of It
4
We Eat Bagels Before Cancer Treatment. Here’s Why.
5